STAT+: Indonesian ruling against ‘patent evergreening’ by pharma industry sends critical message, patient advocates say

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: STAT
STAT+: Indonesian ruling against ‘patent evergreening’ by pharma industry sends critical message, patient advocates sayWorldPing
Image via STAT.

What happened

A recent court decision in Indonesia sends an important message to other countries to challenge the pharma industry's use of "patent evergreening," patient advocates say.

Key facts

  • Reported by STAT and published Thu, 24 Sep 2026 14:57:54 UTC.

Why it matters

Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.

What to watch next

  • Case numbers and official guidance updates
  • Regulatory decisions in other countries
  • Supply, recall or access changes

Coverage timeline

When each newsroom published on this story, oldest first — all times UTC.

  1. STAT+: Pharmalittle: We’re reading about the FDA commissioner nominee, a Lilly partnership in China, and more

  2. STAT+: Indonesian ruling against ‘patent evergreening’ by pharma industry sends critical message, patient advocates say

Sources

The original report was published by STAT. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at STAT

Related WorldPing coverage

Rebel offensive against Ethiopian army stokes fears of return to civil warWorldPing
The Guardian

Rebel offensive against Ethiopian army stokes fears of return to civil war

Fighting escalates after Tigrayan rebels form new coalition aimed at overthrowing Abiy Ahmed government There are growing fears of a return to civil war in Ethiopia after an offensive by fighters from Tigray into the neighbouring states of Afar and A…

Brief by WorldPing · Original reporting by The Guardian